Showing the “Love” for Vision Loss Research
When you first meet the Love boys, Kolton, age 6, and Karson, age 5, you find two active, engaging, and curious young boys who enjoy motor-biking, snowmobiling, playing hockey, and spending time…
Funding the Future: New awards announced to support early career clinician-scientists
Fighting Blindness Canada has awarded three new Clinician Scientist Emerging Leader Awards, helping build the pipeline of ophthalmologist researchers. Clinician-scientists can translate laboratory research into the clinic and help bring clinical trials…
2023 Inherited Retinal Disease Research Updates
September is Inherited Retinal Disease (IRD) Month and we thought it was a great time to share some of the research discoveries that are moving us towards new treatments across different IRDs…
VIEW POINT RECORDINGS
Jump to: AMD | Cataracts | Glaucoma | IRDs and Genetics | Diabetes | Innovative Treatments | FBC Research Awardees | Year in Review and Town Hall | Living Well with Vision Loss | Community Showcase Ffind all of our past webinars on our View Point YouTube Playlist. AGE-RELATED MACULAR DEGENERATION (AMD)…
$1.67 million for transformative research into retinal degeneration
These two awards will fund projects at the forefront of research into glaucoma and inherited retinal diseases. For nearly 50 years, Fighting Blindness Canada has helped move the needle on vision research,…
Canadians now have access to Luxturna!
Luxturna is the first gene therapy treatment approved for an inherited retinal disease in Canada. The treatment is for people who have Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by…
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
